Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
J Vasc Access ; 24(3): 402-408, 2023 May.
Article in English | MEDLINE | ID: mdl-34320865

ABSTRACT

BACKGROUND: The aim of this prospective, randomized, controlled study was to evaluate the analgesic effect of US-guided Pectoral (PECS) I blocks on postoperative analgesia after TIVAP insertion. METHODS: A hundred-twenty patients were included in this study. The patients were divided into two groups: Group PECS and Group INF (infiltration). A total 0.4 mL kg-1 0.25% bupivacaine was injected to below the middle of the clavicle in the interfascial space between the pectoralis major and minor muscles for PECS-1. The skin and deep tissue infiltration of the anterior chest wall was performed with 0.4 mL kg-1 0.25% bupivacaine for INF group. Tramadol and paracetamol consumption, visual analog scale pain scores were recorded at 0, 1, 4, 12, and 24 h postoperatively. RESULTS: The use of the PECS in TIVAP significantly decreased the amount of paracetamol used in the first 24 h postoperatively (p < 0.001). There was a statistically significant difference in the number of tramadol rescue analgesia administered between the groups (p < 0.001) There was no significant difference between the groups in terms of the VAS scores at 0 and 24 h. However, VAS scores at 1, 4, and 12 h were found to be significantly lower in patients who underwent PECS than in those who received infiltration anesthesia (p < 0.001). CONCLUSIONS: This study shows that US-guided PECS-1 provides adequate analgesia following TIVAP insertion as part of multimodal analgesia. The PECS-1 significantly reduced opioid consumption.


Subject(s)
Catheterization, Central Venous , Nerve Block , Tramadol , Humans , Nerve Block/adverse effects , Tramadol/adverse effects , Acetaminophen , Prospective Studies , Pain, Postoperative/diagnosis , Pain, Postoperative/etiology , Pain, Postoperative/prevention & control , Bupivacaine/adverse effects , Catheters
2.
Medicine (Baltimore) ; 101(35): e30290, 2022 Sep 02.
Article in English | MEDLINE | ID: mdl-36107549

ABSTRACT

AIM: To determine effect of ultrasound-guided serratus anterior plane block (SAPB) on intraoperative opioid consumption in patients undergoing oncoplastic breast surgery under general anesthesia. METHODS: This study was conducted as a prospective, randomized controlled trial. Forty-four patients enrolled, aged 18 to 75 years with American Society of Anesthesiologists physical status I to III, undergoing elective oncoplastic breast surgery. Patients were randomly allocated to receive SAPB with 20 mL of 0.25% bupivacaine + general anesthesia (group SAPB) or only general anesthesia (group control). The primary outcome was assessing the effect of SAPB on intraoperative remifentanil consumption. Patients were assessed for emergence time, hemodynamic parameters, doses of rescue drugs used to control hemodynamic parameters, and duration of stay in the recovery room. RESULTS: Preoperative SAPB with 0.25% bupivacaine reduced intraoperative opioid consumption (851.2 ± 423.5 vs 1409.7 ± 756.1 µg, P = .019). Emergence time was significantly shorter in group SAPB (6.19 ± 1.90 minutes) compared to group control (9.50 ± 2.39 minutes; P < .001). There were no significant differences in the doses of rescue drugs used for systolic blood pressure and heart rate between the groups. CONCLUSIONS: Preoperative SAPB with bupivacaine reduced intraoperative opioid consumption and shortened emergence time and duration of stay in the recovery unit, and hemodynamic stability was maintained without block-related complications.


Subject(s)
Analgesics, Opioid , Breast Neoplasms , Breast Neoplasms/complications , Bupivacaine , Female , Hemodynamics , Humans , Pain, Postoperative/drug therapy , Pain, Postoperative/etiology , Pain, Postoperative/prevention & control , Prospective Studies , Remifentanil , Ultrasonography, Interventional/adverse effects
3.
Gen Thorac Cardiovasc Surg ; 70(1): 64-71, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34347237

ABSTRACT

BACKGROUND: The aim of this prospective, randomized, controlled study was to evaluate the analgesic effect of ultrasonography (USG) guided continuous erector spinae plane block (ESPB) for postoperative analgesia in video-assisted thoracoscopic surgery (VATS). METHODS: Eighty American Society of Anesthesiologists (ASA) physical status I-III patients aged 18-75 and who were to undergo VATS were included in this study. Randomization was performed in 2 groups, continuous ESPB (ESPB Group) and no intervention (Control Group). 20 mL of 0.25% bupivacaine was administered for the block. Immediately after surgery, the patient received continuous infusion of 0.125% bupivacaine at 4 mL h-1 via the catheter inserted for the block. Patients in both groups received tramadol via an intravenous patient-controlled analgesia device. Tramadol and meperidine consumption, visual analog scale pain scores and opioid-related side effects were recorded at 0, 1, 4, 8, 12, 24, 36, and 48 h postoperatively. RESULTS: The use of continuous ESPB in VATS significantly decreased the amount of tramadol used in the first 48 h postoperatively (P < 0.001). There was a statistically significant difference in the number of meperidine rescue analgesia administered between the ESPB and Control Groups (P < 0.001). While the incidences of nausea and itching were higher in Control Group, there were no differences in terms of the other side effects between the groups. CONCLUSIONS: This study shows that USG-guided continuous ESPB provides adequate analgesia following VATS as part of multimodal analgesia. Continuous ESPB significantly reduced opioid consumption and opioid-related side effects compared to those in the Control Group.


Subject(s)
Nerve Block , Thoracic Surgery, Video-Assisted , Humans , Pain, Postoperative/diagnosis , Pain, Postoperative/etiology , Pain, Postoperative/prevention & control , Paraspinal Muscles , Prospective Studies , Ultrasonography, Interventional
4.
J Pak Med Assoc ; 71(2(A)): 434-439, 2021 02.
Article in English | MEDLINE | ID: mdl-33819223

ABSTRACT

OBJECTIVE: To determine the predictive tests for difficulty in laryngeal mask airway insertion, and to observe the success rate of insertion in the first attempt. METHODS: The prospective, observational study was conducted at Bülent Ecevit University Hospital, Turkey, from September 2013 to 2014, and comprised patients of American Society of Anaesthesiologists grade I to IV adult patients who underwent elective surgery under general anaesthesia. The supraglottic airway device was randomly selected for each patient, and the laryngeal mask airway was used as per the decision of an anaesthesiologist who was not part of the study. Patients were divided into three groups according to laryngeal mask airway types as classic group A, i-gel group B and suprema group C. These were inserted by anaesthesia residents with the same seniority when bispectral index value reached 40-60. Data was noted and analysed using SPSS 24. RESULTS: Of the 120 patients, 40(33.33%) were in cLMA, 38(31.66%) in i-gel, and 42(35%) in sLMA. There was no significant difference among the groups in terms of demographics (p>0.05). Apart from the height/thyromental distance ratio (p=0.046), no predictive test was statistically significant in identifying the difficulty in laryngeal mask airway insertion (p>0.05). There was no significant difference involving number of attempts, difficulty in insertion, and patient response (p>0.05). Placement success rate at first attempt was similar among the groups (p>0.05). CONCLUSIONS: Higher height/thyromental distance ratio values were associated with difficulty in laryngeal mask airway insertion, and first-attempt success rate was similar in all the three laryngeal mask airway types.


Subject(s)
Laryngeal Masks , Adult , Anesthesia, General , Elective Surgical Procedures , Humans , Prospective Studies , Turkey
5.
J Pak Med Assoc ; 70(10): 1742-11747, 2020 Oct.
Article in English | MEDLINE | ID: mdl-33159745

ABSTRACT

OBJECTIVE: To demonstrate that two lung ventilation under general anaesthesia may also be safely performed to create pericardial window with uniportal video-assisted thoracoscopic surgery. METHOD: The single-centre, retrospective, comparative study was conducted at Bulent Ecevit University, Zonguldak, Turkey, comprised data from March 2011 to March 2018 of patients with recurrent and/or with chronic large pericardial effusions unresponsive to medical therapy and/or to pericardiocentesis and who underwent pericardial window creation with uniportal video-assisted thoracoscopic surgery. Group 1 had data of patients in whom pericardial windows were created under general anaesthesia, while group 2 had patients with two lung ventilation. Parameters compared between the groups were gender, age, operation side, operation time amount of drainage, complication, recurrences and survival. Data was analysed using SPSS 19. RESULTS: Of the 20 patients, 9(45%) were males and 11(55%) were females. Group 1 had 14(70%) patients, while group 2 had 6(30%). The age of patients in group 2 was significantly higher than those in group 1 (p=0.041). There was no significant difference between the groups with respect to gender, amount of drainage, operation time and post-operative complications (p>0.05). There was no recurrence or mortality in either of the two groups. CONCLUSIONS: Pericardial window could be created safely with video-assisted thoracoscopic surgery under two lung ventilation for patients carrying high risk for one lung ventilation.


Subject(s)
Pericardial Effusion , Thoracic Surgery, Video-Assisted , Female , Humans , Lung , Male , Pericardial Effusion/surgery , Retrospective Studies , Turkey
6.
Turk Kardiyol Dern Ars ; 48(4): 439-442, 2020 06.
Article in English | MEDLINE | ID: mdl-32519987

ABSTRACT

Carbon monoxide (CO) poisoning is the most common cause of poisoning-related death in the world. Cardiovascular complications of CO intoxication includes myocardial damage, left ventricular dysfunction, pulmonary edema, and arrhythmias. The carboxyhemoglobin level does not correlate with the clinical severity of CO intoxication. This case report presents a patient with acute myocardial infarction secondary to carbon monoxide poisoning who was successfully treated with coronary bypass surgery.


Subject(s)
Carbon Monoxide Poisoning/complications , Carboxyhemoglobin/analysis , Coronary Artery Bypass/methods , Non-ST Elevated Myocardial Infarction/etiology , Aged , Chest Pain/diagnosis , Chest Pain/etiology , Coronary Angiography/methods , Echocardiography/methods , Electrocardiography/methods , Female , Humans , Nausea/diagnosis , Nausea/etiology , Non-ST Elevated Myocardial Infarction/diagnosis , Treatment Outcome , Vomiting/diagnosis , Vomiting/etiology
7.
Regul Toxicol Pharmacol ; 104: 128-132, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30878575

ABSTRACT

Radiation induced colitis is one the most common clinical issue for patients receiving radiotherapy. For this reason, we aimed to investigate the effect of antioxidant-effective flavonoids hesperidin and quercetin on the intestinal damage induced by radiation in this study. TNF-alpha, interleukin-10 (IL-10), heat shock protein 70 (HSP 70) and caspase 3, 8, 9 markers of apoptotic pathways were measured in the colon tissues of irradiated acute intestinal damage by enzyme-linked immunosorbent assay (ELISA). Irradiation of rats caused a significance increase of TNF-alpha, caspase 3/8/9 and decrease of IL-10 concentrations. Hesperidin and quercetin treatment resulted in decreased levels of TNF-alpha and increased levels of IL-10. Quercetin significantly decreased caspase 3/8/9 levels. Hesperidin produced a decreased of caspase 3/8/9 levels compared with irradiation group but this was statistically not significant. Only significant alteration of HSP 70 were seen in hesperidin treated rats. Further studies are needed to elucidate the mechanism by which flavonoids induced signaling provides protection against apoptosis and inflammation.


Subject(s)
Antioxidants/pharmacology , Colitis/etiology , Colitis/prevention & control , Colon/drug effects , Hesperidin/pharmacology , Protective Agents/pharmacology , Quercetin/pharmacology , X-Rays/adverse effects , Animals , Antioxidants/administration & dosage , Caspase 3/analysis , Caspase 3/metabolism , Caspase 9/analysis , Caspase 9/metabolism , Colitis/metabolism , Colon/metabolism , Enzyme-Linked Immunosorbent Assay , Hesperidin/administration & dosage , Inflammation/metabolism , Inflammation/prevention & control , Interleukin-10/analysis , Interleukin-10/metabolism , Male , Protective Agents/administration & dosage , Quercetin/administration & dosage , Radiotherapy/adverse effects , Rats , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/metabolism
8.
J Radiat Res ; 59(4): 404-410, 2018 Jul 01.
Article in English | MEDLINE | ID: mdl-29688418

ABSTRACT

Extensive research has been focused on radiation-induced brain injury. Animal and human studies have shown that flavonoids have remarkable toxicological profiles. This study aims to investigate the neuroprotective effects of quercetin in an experimental radiation-induced brain injury. A total of 32 adult male Wistar-Albino rats were randomly divided into four groups (control, quercetin, radiation, and radiation+quercetin groups, with eight rats in each group). Doses (50 mg/kg) of quercetin were administered to the animals in the quercetin and radiation+quercetin groups; radiation and radiation+quercetin groups were exposed to a dose of 20 Gy to the cranium region. Tissue samples, and biochemical levels of tissue injury markers in the four groups were compared. In all measured parameters of oxidative stress, administration of quercetin significantly demonstrated favorable effects. Both plasma and tissue levels of malondialdehyde and total antioxidant status significantly changed in favor of antioxidant activity. Histopathological evaluation of the tissues also demonstrated a significant decrease in cellular degeneration and infiltration parameters after quercetin administration. Quercetin demonstrated significant neuroprotection after radiation-induced brain injury. Further studies of neurological outcomes under different experimental settings are required in order to achieve conclusive results.


Subject(s)
Brain Injuries/drug therapy , Neuroprotective Agents/therapeutic use , Quercetin/therapeutic use , Radiation Injuries, Experimental/drug therapy , Animals , Brain Injuries/blood , Brain Injuries/pathology , Cerebral Cortex/pathology , Male , Malondialdehyde/blood , Neuroprotective Agents/pharmacology , Quercetin/pharmacology , Radiation Injuries, Experimental/blood , Radiation Injuries, Experimental/pathology , Rats, Wistar
9.
Turk Gogus Kalp Damar Cerrahisi Derg ; 26(3): 464-466, 2018 Jul.
Article in English | MEDLINE | ID: mdl-32082779

ABSTRACT

Moyamoya disease is a chronic cerebrovascular disease characterized by the development of compensatory collateral vessels due to progressive narrowing or obstruction of the intracranial arteries. Neurological complications after coronary bypass in patients with Moyamoya disease may be prevented by recent technical developments, surgical modifications, and cerebral monitorization. The objective of perioperative anesthetic management is to provide balance between oxygen supply and consumption of the brain. In this case report, we aim to share our anesthetic experience in a patient with Moyamoya disease who underwent off-pump coronary artery bypass surgery and cerebral oximetry monitoring.

10.
J Pak Med Assoc ; 67(4): 561-567, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28420916

ABSTRACT

OBJECTIVE: To evaluate respiratory function in the post-operative early period of patients undergoing bariatric surgery using the sleeve gastrectomy technique. METHODS: This prospective, observational study was conducted at Bülent Ecevit University Health Application and Research Centre, Zonguldak, Turkey from June to December 2014, and comprised patients with planned bariatric sleeve gastrectomy under general anaesthesia. Participants were visited 12-24 hours before the operation to record accompanying diseases and demographic data. Before the operations, respiratory function test, maximum expiratory pressure, maximum inspiratory pressure and arterial blood gas assessment tests were done and recorded as T0. After one hour of the operation, Aldrete scores >9 and the above-mentioned tests were repeated and recorded as T1. SPSS 18 and MedCalc 12.2.1.0 were used for statistical analysis. RESULTS: Of the 76 participants, 60(78%) were women and 16(21%) were men. The overall median age was 39 years (inter-quartile range: 32-47 years). The mean and median values for forced expiratory volume in 1 second, forced vital capacity, maximum inspiratory pressure, maximum expiratory pressure and the ratio between partial pressure of oxygen in arterial blood and fraction of inspired oxygen at T0 were 101±17, 102±17, 66 (interquartile range: 59-74), 114 (interquartile range: 100-138) and 379±49, respectively, compared with 78±18, 76±18, 53 (interquartile range: 48-59), 85 (interquartile range: 73-95) and 331±49at T1 (p<0.001 each). Also, 38(50%) participants were given sugammadex and 38(50%) were given neostigmine. At the end of the test, sugammadex (odds ratio: 5.80; 95% confidence interval: 1.26-26.69; p=0.024) and pre-operative ratio between partial pressure of oxygen in arterial blood and fraction of inspired oxygen (odds ratio: 1.04, 95% confidence interval: 1.02-1.06; p<0.0001) were found to correlate significantly. CONCLUSIONS: Impairment of respiratory function was found during the early post-operative period.


Subject(s)
Anesthesia, General/methods , Bariatric Surgery/methods , Gastrectomy/methods , Postoperative Complications/epidemiology , Respiration Disorders/epidemiology , Adult , Anesthetics, Inhalation/therapeutic use , Anesthetics, Intravenous/therapeutic use , Blood Gas Analysis , Cholinesterase Inhibitors/therapeutic use , Female , Fentanyl/therapeutic use , Forced Expiratory Volume , Humans , Intubation, Intratracheal , Logistic Models , Male , Maximal Respiratory Pressures , Middle Aged , Multivariate Analysis , Muscle Strength , Neostigmine/therapeutic use , Neuromuscular Nondepolarizing Agents/therapeutic use , Nitrous Oxide/therapeutic use , Odds Ratio , Oximetry , Partial Pressure , Postoperative Complications/physiopathology , Propofol/therapeutic use , Respiration Disorders/physiopathology , Respiratory Muscles , Rocuronium/therapeutic use , Sevoflurane/therapeutic use , Sugammadex/therapeutic use , Vital Capacity
11.
Braz J Anesthesiol ; 66(4): 376-82, 2016.
Article in English | MEDLINE | ID: mdl-27343787

ABSTRACT

BACKGROUND AND OBJECTIVE: Sugammadex is the first selective relaxant binding agent. When compared with neostigmine, following sugammadex administration patients wake earlier and have shorter recovery times. In this study, we hypothesized that fast and clear awakening in patients undergoing general anesthesia has positive effects on cognitive functions in the early period after operation. METHODS: Approved by the local ethical committee, 128 patients were enrolled in this randomized, prospective, controlled, double-blind study. Patients were allocated to either Sugammadex group (Group S) or the Neostigmine group (Group N). The primary outcome of the study was early postoperative cognitive recovery as measured by the Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE). After baseline assessment 12-24h before the operation. After the operation, when the Modified Aldrete Recovery Score was ≥9 the MMSE and 1h later the MoCA tests were repeated. RESULTS: Although there was a reduction in MoCA and MMSE scores in both Group S and Group N between preoperative and postoperative scores, there was no statistically significant difference in the slopes (p>0.05). The time to reach TOF 0.9 was 2.19min in Group S and 6.47min in Group N (p<0.0001). Recovery time was 8.26min in Group S and 16.93min in Group N (p<0.0001). CONCLUSION: We showed that the surgical procedure and/or accompanying anesthetic procedure may cause a temporary or permanent regression in cognitive function in the early postoperative period. However, better cognitive performance could not be proved in the Sugammadex compared to the Neostigmine.


Subject(s)
Anesthesia Recovery Period , Cognition/drug effects , gamma-Cyclodextrins/pharmacology , Adult , Anesthesia, General , Double-Blind Method , Female , Humans , Male , Neostigmine/pharmacology , Postoperative Period , Prospective Studies , Sugammadex
12.
Rev Bras Anestesiol ; 66(4): 376-82, 2016.
Article in Portuguese | MEDLINE | ID: mdl-27157202

ABSTRACT

BACKGROUND AND OBJECTIVE: Sugammadex is the first selective relaxant binding agent. When compared with neostigmine, following sugammadex administration patients wake earlier and have shorter recovery times. In this study, we hypothesized that fast and clear awakening in patients undergoing general anesthesia has positive effects on cognitive functions in the early period after operation. METHODS: Approved by the local ethical committee, 128 patients were enrolled in this randomized, prospective, controlled, double-blind study. Patients were allocated to either Sugammadex group (Group S) or the Neostigmine group (Group N). The primary outcome of the study was early postoperative cognitive recovery as measured by the Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE). After baseline assessment 12-24h before the operation. After the operation, when the Modified Aldrete Recovery Score was ≥9 the MMSE and 1h later the MoCA tests were repeated. RESULTS: Although there was a reduction in MoCA and MMSE scores in both Group S and Group N between preoperative and postoperative scores, there was no statistically significant difference in the slopes (p>0.05). The time to reach TOF 0.9 was 2.19min in Group S and 6.47min in Group N (p<0.0001). Recovery time was 8.26min in Group S and 16.93min in Group N (p<0.0001). CONCLUSION: We showed that the surgical procedure and/or accompanying anesthetic procedure may cause a temporary or permanent regression in cognitive function in the early postoperative period. However, better cognitive performance could not be proved in the Sugammadex compared to the Neostigmine.

SELECTION OF CITATIONS
SEARCH DETAIL
...